echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Accelerated clinical trial research, EU work plan 2022-2026 released

    Accelerated clinical trial research, EU work plan 2022-2026 released

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On 30 August, the European Commission (EC), Heads of Pharmaceutical Institutions (HMA) and the European Medicines Agency (EMA) released the EU Accelerated Clinical Trials Study (ACT-EU) work plan


    The work plan builds on the recommendations of the European Drug Regulatory Network (EMRN) Strategy 2025 and the European Commission's European Medicines Strategy, with emphasis on further promoting clinical trial innovation, stakeholder engagement and regulatory focus areas


    At the same time, the work plan sets out deliverables and timelines, including:

    Clinical trials for large multinationals: Establish a support process specifically for academic sponsors to make the EU a more attractive clinical research region


    Clinical trials for large multinational corporations:

    Implementation of CTR: Special attention is paid to clinical trial information systems (CTIS) and EU Clinical Trial Regulation (CTR) training activities and addressing any issues encountered by clinical trial sponsors


    Implementation of CTR:

    Multi-stakeholder platform: To be established in 2023, it will facilitate the evolution of the clinical trial environment through regular dialogues between all stakeholders, including patients, medical professionals, and academia, to find practical solutions


    Multi-stakeholder platform:

    Modern good clinical practice: The clinical research program will support not only the adoption of revised EU guidelines in terms of technology and clinical trial design, but also their implementation


    Modern good clinical practice:

    Decentralized Clinical Trials: The plan will release decentralized clinical trials by the end of 2022 and publish a method roadmap to identify and prioritize key advances in clinical trial approaches


    Decentralized Clinical Trials:

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.